Machine learning (ml) in the pharmaceutical industry market to reach $18.71 billion by 2030 at 35.7% CAGR, driven by increasing adoption of artificial intelligence (ai).
Read More
Mrna therapeutics market to reach $42.32 billion by 2030 at 3.3% CAGR, driven by increasing prevalence of long-lasting and communicable diseases.
Read More
Lysosomal enzyme market to reach $13.49 billion by 2030 at 6.0% CAGR, driven by increasing adoption of gene therapy.
Read More
Mrna cancer vaccines and therapeutics market to reach $141.51 billion by 2030 at 14.4% CAGR, driven by rising prevalence of cancer.
Read More
Lysosomal disease treatment market to reach $14.73 billion by 2030 at 8.7% CAGR, driven by growing diagnostic activities.
Read More
Morphine drugs market to reach $30.17 billion by 2030 at 5.3% CAGR, driven by increasing prevalence of chronic pain conditions.
Read More
Lyophilized injectable drugs market to reach $4.87 billion by 2030 at 4.2% CAGR, driven by rising incidence of cardiac disorders.
Read More
The global montelukast sodium market to reach $6.33 billion by 2030 at 8.4% CAGR, driven by increasing prevalence of asthma.
Read More
Lymphocyte activating gene 3 (lag3) antibody market to reach $1.53 billion by 2030 at 13.9% CAGR, driven by rising cancer incidence.
Read More
Monoclonal antibody therapeutics market to reach $396.1 billion by 2030 at 11.9% CAGR, driven by rising prevalence of autoimmune diseases.
Read More